Study to Evaluate Safety and Biological Activity of TroVax® Vaccine Given in Conjunction With IL-2 to Treat Locally Advanced or Metastatic Renal Cell Carcinoma
This study has been completed.
Sponsor:
Oxford BioMedica
Collaborators:
The Methodist Hospital System
ORION Clinical Services
Information provided by:
Oxford BioMedica
ClinicalTrials.gov Identifier:
NCT00325507
First received: May 10, 2006
Last updated: July 31, 2008
Last verified: July 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2008 |
| Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |